Skip to main content
The CDT uses studies of childhood diseases and development to identify mechanisms and principles that can be translated into children’s health improvements.
The CDT’s research cores help investigators understand and develop treatments for some of today’s most pressing childhood health problems.
The Neonatal Respiratory Support Technologies team is developing affordable, easy-to-use and easy-to-maintain respiratory support solutions.
Dr. Michael Portman is unraveling how the heart responds to injury, and identifying supplements that prevent damage and accelerate recovery.
Reproducibility: In praise of open research measures. Nature. 2013 Jun 13;498(7453):170. doi: 10.1038/498170b. Kolker E.
Prepregnancy body mass index and congenital heart defects among offspring: a population-based study. Congenit Heart Dis. 2013 Mar-Apr;8(2):131-41. doi: 10.1111/j.1747-0803.2012.00714.x. Epub 2012 Sep 12. Madsen NL, Schwartz SM, Lewin MB, Mueller BA.
Kawasaki disease and soy: potential role for isoflavone interaction with Fcγ receptors. Pediatr Res. 2013 Feb;73(2):130-4. doi: 10.1038/pr.2012.168. Epub 2012 Nov 20. Portman MA.
C-Myc induced compensated cardiac hypertrophy increases free fatty acid utilization for the citric acid cycle. J Mol Cell Cardiol. 2013 Feb;55:156-64. doi: 10.1016/j.yjmcc.2012.07.005. Olson AK, Ledee D, Iwamoto K, Kajimoto M, O'Kelly Priddy C, Isern N, Portman MA.
Email the CDT
1900 Ninth Avenue
Seattle, WA 98101
PO Box 5371
Seattle, WA 98145-5005
More than half of the kids who come to Seattle Children’s live with serious conditions that they will have for the rest of their lives. Research can give them a different future. Your support makes it possible.
Seattle Urban Trek
Genetics and Molecular Basis of Novel Primary Immunodeficiencies
CCTR Science Day
Seattle Children’s provides healthcare for the special needs of children regardless of race, color, creed, national origin, religion, sex (gender), sexual orientation or disability. Financial assistance for medically necessary services is based on family income and hospital resources and is provided to children under age 21 whose primary residence is in Washington, Alaska, Montana or Idaho.
© 1995-2014 Seattle Children’s Hospital, Research and Foundation